A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/135 (2006.01) A61J 3/07 (2006.01) A61K 9/20 (2006.01) A61K 9/24 (2006.01) A61K 9/26 (2006.01) A61K 47/36 (2006.01) A61K 9/28 (2006.01)
Patent
CA 2503361
A solid dosage formulation having a core with a pharmacological agent dispersed in a first controlled-release matrix from which release of the agent is relatively slow; and a coat formed over the core and having the agent dispersed in a second controlled-release matrix from which release of the agent is relatively fast. The first matrix can be a cross-linked high amylose starch and the second matrix can be a mixture of polyvinyl acetate and polyvinylpyrrolidone.
Formulation à dosage solide possédant un noyau avec un agent pharmacologique dispersé dans une première matrice à libération contrôlée qui libère l'agent d'une manière relativement lente, et revêtement formé sur le noyau et dans lequel l'agent pharmacologique est dispersé dans une deuxième matrice à libération relativement rapide. La première matrice peut être un amidon réticulé à haute teneur en amylose, et la deuxième matrice peut être un mélange d'acétate de polyvinyle et de polyvinylpyrrolidone.
Bacon Johnatan
Gervais Sonia
Lenaerts Vincent
Ouadji-Njiki Patricia Laure
Ouzerourou Rachid
Borden Ladner Gervais Llp
Labopharm (barbados) Limited
Labopharm Europe Limited
Labopharm Inc.
LandOfFree
Controlled-release compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Controlled-release compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Controlled-release compositions will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1715641